secikinumab
Showing 1 - 1 of 1
Psoriasis Trial in Worldwide (Secikinumab)
Active, not recruiting
- Psoriasis
- Secikinumab
-
Adrogué, Buenos Aires, Argentina
- +80 more
Oct 14, 2022